BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 12554650)

  • 1. Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex.
    Dajani R; Fraser E; Roe SM; Yeo M; Good VM; Thompson V; Dale TC; Pearl LH
    EMBO J; 2003 Feb; 22(3):494-501. PubMed ID: 12554650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation.
    Ha NC; Tonozuka T; Stamos JL; Choi HJ; Weis WI
    Mol Cell; 2004 Aug; 15(4):511-21. PubMed ID: 15327768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization.
    Fagotto F; Jho Eh; Zeng L; Kurth T; Joos T; Kaufmann C; Costantini F
    J Cell Biol; 1999 May; 145(4):741-56. PubMed ID: 10330403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axin negatively affects tau phosphorylation by glycogen synthase kinase 3beta.
    Stoothoff WH; Bailey CD; Mi K; Lin SC; Johnson GV
    J Neurochem; 2002 Nov; 83(4):904-13. PubMed ID: 12421363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
    Jho Eh; Lomvardas S; Costantini F
    Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
    Sakanaka C; Weiss JB; Williams LT
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
    Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T
    Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin.
    Hedgepeth CM; Deardorff MA; Rankin K; Klein PS
    Mol Cell Biol; 1999 Oct; 19(10):7147-57. PubMed ID: 10490650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
    Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
    Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of the Axin-adenomatous polyposis coli interaction.
    Spink KE; Polakis P; Weis WI
    EMBO J; 2000 May; 19(10):2270-9. PubMed ID: 10811618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification.
    Farr GH; Ferkey DM; Yost C; Pierce SB; Weaver C; Kimelman D
    J Cell Biol; 2000 Feb; 148(4):691-702. PubMed ID: 10684251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
    Yuan H; Mao J; Li L; Wu D
    J Biol Chem; 1999 Oct; 274(43):30419-23. PubMed ID: 10521419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Wnt signaling by Axin and Axil.
    Kikuchi A
    Cytokine Growth Factor Rev; 1999; 10(3-4):255-65. PubMed ID: 10647780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase-3 and Axin function in a beta-catenin-independent pathway that regulates neurite outgrowth in neuroblastoma cells.
    Orme MH; Giannini AL; Vivanco MD; Kypta RM
    Mol Cell Neurosci; 2003 Nov; 24(3):673-86. PubMed ID: 14664817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex.
    Willert K; Shibamoto S; Nusse R
    Genes Dev; 1999 Jul; 13(14):1768-73. PubMed ID: 10421629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
    Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
    EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway.
    Furuhashi M; Yagi K; Yamamoto H; Furukawa Y; Shimada S; Nakamura Y; Kikuchi A; Miyazono K; Kato M
    Mol Cell Biol; 2001 Aug; 21(15):5132-41. PubMed ID: 11438668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex.
    Xing Y; Clements WK; Kimelman D; Xu W
    Genes Dev; 2003 Nov; 17(22):2753-64. PubMed ID: 14600025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta-catenin and down-regulates beta-catenin.
    Hinoi T; Yamamoto H; Kishida M; Takada S; Kishida S; Kikuchi A
    J Biol Chem; 2000 Nov; 275(44):34399-406. PubMed ID: 10906131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta.
    Behrens J; Jerchow BA; Würtele M; Grimm J; Asbrand C; Wirtz R; Kühl M; Wedlich D; Birchmeier W
    Science; 1998 Apr; 280(5363):596-9. PubMed ID: 9554852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.